Compare · MDLN vs NYXH
MDLN vs NYXH
Side-by-side comparison of Medline Inc. (MDLN) and Nyxoah SA (NYXH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and NYXH operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.77B, about 294.3x NYXH ($152.1M).
- Over the past year, MDLN is down 16.5% and NYXH is down 72.6% - MDLN leads by 56.1 points.
- MDLN has been more active in the news (4 items in the past 4 weeks vs 3 for NYXH).
- MDLN has more recent analyst coverage (25 ratings vs 9 for NYXH).
PerformanceMDLN-16.47%NYXH-68.20%
2025-12-17+0.00%2026-09-09
- Company
- Medline Inc.
- Nyxoah SA
- Price
- $34.04-1.90%
- $1.52-2.25%
- Market cap
- $44.77B
- $152.1M
- 1M return
- +0.72%
- -3.49%
- 1Y return
- -16.47%
- -72.56%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2021
- News (4w)
- 4
- 3
- Recent ratings
- 25
- 9
NYXH
Nyxoah SA
Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium.
Latest MDLN
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
Latest NYXH
- Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
- Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
- Information on the total number of voting rights and shares
- Amendment: SEC Form SCHEDULE 13G/A filed by Nyxoah SA
- SEC Form 6-K filed by Nyxoah SA
- Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results
- Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
- SEC Form 6-K filed by Nyxoah SA
- Nyxoah Announces Preliminary Results for the Second Quarter of 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Nyxoah SA